AbbVie received Food and Drug Administration approval of Emblaveo, an intravenous antibiotic, for treatment of adults with complicated intra-abdominal infections with limited or no treatment options.

AbbVie received Food and Drug Administration approval of Emblaveo, an intravenous antibiotic, for treatment of adults with complicated intra-abdominal infections with limited or no treatment options.

AbbVie (ABBV) said it has received FDA approval for the combination antibiotic treatment Emblaveo, which was co-developed ...

The FDA has approved the intravenous antibiotic Emblaveo for adults with complicated intra-abdominal infections who have limited treatment options.

Back in April, just before his 17th birthday, Aiden had been feeling run down and tired. He figured it was an iron deficiency ...

Loose Women favourite Andrea McLean has bravely spoken out about a harrowing health ordeal that led to her being rushed to hospital after she collapsed at home. The 54-year-old, who bid farewell to ...

The first, the traditional one, is to initiate with parenteral antibiotics and continue for the entire course. The second option is switch therapy -- starting with intravenous antibiotics and then ...

Here are 5 illnesses you might not know that you can treat from your own home with Mobile Inpatient Care at Home ...

NORTH CHICAGO, Ill. - The U.S. Food and Drug Administration (FDA) has approved EMBLAVEO™ (aztreonam and avibactam) for the ...

Iterum Therapeutics plc (Nasdaq: ITRM), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and ...

AbbVie has received US FDA approval for Emblaveo to be used in conjunction with metronidazole for individuals with cIAI.